A Randomized Trial of Wise Guys: The Next Level

智者的随机试验:下一个水平

基本信息

项目摘要

Project Summary/Abstract Sexual violence (SV) is a highly prevalent, significant public health problem resulting in serious health, economic, and social consequences. Like other forms of violence, SV is preventable. Through its Rape Prevention and Education (RPE) program, the CDC has funded states to strengthen the SV prevention efforts of community organizations. However, the evidence base for these efforts is weak, and how best to prevent SV perpetration remains unclear. Our study will rigorously evaluate an ongoing RPE-funded program, Wise Guys: The Next Level (WGNL), which addresses SV perpetration by addressing known risk and protective factors, such as rape culture and unhealthy masculinity, gender stereotyping, communication and consent in relationships. WGNL is based on an evidence-informed theory of change and is implemented by Children's Home Society of North Carolina (CHSNC), a well-established community-based organization that has been working with men and boys since the 1990s. CHS currently implements WGNL in numerous sites that serve boys and young men at high risk for SV perpetration. In Year 1, our research team will work with CHSNC and the North Carolina Coalition Against Sexual Assault, as well as our Research Advisory Board, to identify, refine, and document the core components and activities of WGNL and formalize its implementation by CHSNC personnel. In Years 2 to 4, we will use a cluster-randomized design to randomize WGNL implementation by site and time. A total of 520 participants will be enrolled. Participants will be evaluated at pre-program (baseline), immediate post-program (2-month), and 12-month follow-up. The evaluation will be designed to measure the effect of WGNL on the primary outcome of preventing SV perpetration and, secondarily, on preventing dating violence, bullying, sexual risk behavior, and harassment. We will document the implementation costs of WGNL to inform future research and SV prevention interventions. Our proposed research addresses several research priorities identified in the CDC Injury Research Agenda for 2009-2018, including “evaluating approaches to prevent SV that target high-risk populations and shared risk factors with other health outcomes” and “evaluating the effectiveness of SV prevention approaches with substantial uptake and informed by evidence, but without evaluation research evidence.” Our research team has a long history of collaboration with practitioners in the SV prevention community. Our use of a practice-informed evidence research paradigm will optimize dissemination of study results to the practitioner community, and increase the probability that this program, if found to be effective, can replicated with fidelity and sustainability in other communities.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATHRYN Elizabeth MORACCO其他文献

KATHRYN Elizabeth MORACCO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

相似海外基金

High Performance Reefable Wingsail Rig Design and Pre-deployment Trial
高性能可折叠翼帆装置设计和预部署试验
  • 批准号:
    10092779
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    Collaborative R&D
Pulmonary rehabilitation delivered in low resource settings for people with chronic respiratory disease: a 3-arm assessor-blind implementation trial
在资源匮乏的环境中为慢性呼吸道疾病患者提供肺康复:一项三臂评估者盲法实施试验
  • 批准号:
    MR/Y004809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    Research Grant
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
  • 批准号:
    23K24566
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A mobile health solution in combination with behavioral change approach to improve vaccination coverage and timeliness in Bangladesh: A cluster randomized control trial
移动健康解决方案与行为改变方法相结合,以提高孟加拉国的疫苗接种覆盖率和及时性:集群随机对照试验
  • 批准号:
    24K20168
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Memory Reshaping for Depression: A Remote Digital Randomised Controlled Feasibility Trial
抑郁症记忆重塑:远程数字随机控制可行性试验
  • 批准号:
    MR/Y008545/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    Research Grant
Adaptive platform trialを用いた臨床研究基盤構築によるARDSの人工呼吸戦略の検討
通过使用自适应平台试验构建临床研究基础设施来检查 ARDS 的人工通气策略
  • 批准号:
    24K12148
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
  • 批准号:
    2898794
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    Studentship
MONALISA: A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
MONALISA:一项 SIOPEN 实用临床试验,通过液体活检监测神经母细胞瘤复发 敏感性分析
  • 批准号:
    10103126
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    EU-Funded
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis (MONALISA)
SIOPEN 通过液体活检敏感性分析 (MONALISA) 监测神经母细胞瘤复发的实用临床试验
  • 批准号:
    10110442
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    EU-Funded
A benefit-risk trial of 1-month rifapentine and isoniazid to prevent tuberculosis and reduce morbidity in people with non-communicable multimorbidity
一项为期 1 个月的利福喷汀和异烟肼预防结核病并降低非传染性多病患者发病率的效益风险试验
  • 批准号:
    MR/Y004914/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了